LNWTC
INSM icon

Laird Norton Wetherby Trust Company’s Insmed INSM Stock Holding History

Laird Norton Wetherby Trust Company’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$545K Buy
3,335
+921
+38% +$142K 0.01% 665
2025
Q4 		$420K Buy
+2,414
New +$441K 0.01% 771

Other funds holding INSM

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Laird Norton Wetherby Trust Company's INSM Position: Q1 2026 in Review

Laird Norton Wetherby Trust Company increased its Insmed (INSM) stake by 38% in Q1 2026, buying an estimated $142K and bringing the position to 3,335 shares worth $545K. The position accounts for 0.01% of the portfolio, ranked #665.

Laird Norton Wetherby Trust Company first reported a position in INSM in Q4 2025 and has held it in 2 quarters since. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • Laird Norton Wetherby Trust Company held 3,335 shares of Insmed worth $545K as of Q1 2026.
  • Laird Norton Wetherby Trust Company bought 921 Insmed shares in Q1 2026, an estimated $142K.
  • Insmed made up 0.01% of Laird Norton Wetherby Trust Company's portfolio in Q1 2026, its #665 holding.
  • Laird Norton Wetherby Trust Company first reported a position in Insmed in Q4 2025 and has held it in 2 quarters since.
  • 669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Laird Norton Wetherby Trust Company's 13F filing for Q1 2026, filed 15 May 2026.